These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 994000)

  • 1. Effect of temperature on binding of warfarin by human serum albumin.
    Oester YT; Keresztes-Nagy S; Mais RF; Becktel J; Zaroslinski JF
    J Pharm Sci; 1976 Nov; 65(11):1673-7. PubMed ID: 994000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
    Maes V; Engelborghs Y; Hoebeke J; Maras Y; Vercruysse A
    Mol Pharmacol; 1982 Jan; 21(1):100-7. PubMed ID: 7132952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated effects of liver cirrhosis on the albumin binding sites for diazepam, salicylic acid and warfarin.
    Kober A; Jenner A; Sjöholm I
    Biochem Pharmacol; 1978; 27(23):2729-35. PubMed ID: 728226
    [No Abstract]   [Full Text] [Related]  

  • 4. Induced optical activity following the binding of warfarin, indomethacin, 4-hydroxycoumarin and salicylic acid to human serum albumin.
    Perrin JH; Nelson DA
    Life Sci I; 1972 Mar; 11(6):277-83. PubMed ID: 4653203
    [No Abstract]   [Full Text] [Related]  

  • 5. Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.
    Mais RF; Keresztes-Nagy S; Zaroslinski JF; Oester YT
    J Pharm Sci; 1974 Sep; 63(9):1423-7. PubMed ID: 4427265
    [No Abstract]   [Full Text] [Related]  

  • 6. Stopped-flow studies on drug-protein binding. 1. Kinetics of warfarin binding to human serum albumin.
    Rietbrock N; Lassmann A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):269-74. PubMed ID: 7432558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of the N-B transition of albumin for the binding of warfarin in human serum.
    van der Giesen WF; Wilting J
    Biochem Pharmacol; 1983 Jan; 32(2):281-5. PubMed ID: 6870956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of tolmetin and salicylic acid to human serum albumin as a function of temperature.
    Behm HL; Flynn GL; Wagner JG
    Biopharm Drug Dispos; 1981; 2(3):235-44. PubMed ID: 7295880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants.
    Watanabe H; Kragh-Hansen U; Tanase S; Nakajou K; Mitarai M; Iwao Y; Maruyama T; Otagiri M
    Biochem J; 2001 Jul; 357(Pt 1):269-74. PubMed ID: 11415459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone.
    O'Reilly RA
    Ann N Y Acad Sci; 1973 Nov; 226():293-308. PubMed ID: 4520398
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of temperature on the binding of salicylate by human serum albumin.
    Zaroslinski JF; Keresztes-Nagy S; Mais RF; Oester YT
    Biochem Pharmacol; 1974 Jun; 23(12):1767-76. PubMed ID: 4841305
    [No Abstract]   [Full Text] [Related]  

  • 12. Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels.
    Wosilait WD
    Eur J Clin Pharmacol; 1976 Feb; 9(4):285-90. PubMed ID: 971712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamics of the binding of salicylate to human serum albumin: evidence of non-competition with imidazole.
    Matias I; Ceballos A; Gonzalez-Velasco F; Cachaza JM
    J Pharm Pharmacol; 1989 Feb; 41(2):123-5. PubMed ID: 2568420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced warfarin binding of albumin variants.
    Wilding G; Blumberg ES; Vesell ES
    Science; 1977 Mar; 195(4282):991-4. PubMed ID: 841323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin-binding interactions of sodium valproate.
    Fleitman JS; Bruni J; Perrin JH; Wilder BJ
    J Clin Pharmacol; 1980; 20(8-9):514-7. PubMed ID: 6776162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site. Binding of dicoumarol to the warfarin, indole and benzodiazepine binding sites.
    Fehske KJ; Müller WE; Wollert U; Velden LM
    Mol Pharmacol; 1979 Nov; 16(3):778-89. PubMed ID: 93690
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations between high-affinity binding sites of markers for binding regions on human serum albumin.
    Kragh-Hansen U
    Biochem J; 1985 Feb; 225(3):629-38. PubMed ID: 3977850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.